1154: Value of Color Doppler Coronary Flow Imaging and Myocardial Contrast Echocardiography for Monitoring The Safety and Efficacy During Transcoronary Septal Ablation in Patients With Hypertrophic Cardiomyopathy

Yihua He,Zhian Li,Xiaoyan Gu,Michael C. Kontos,J.V. Ian Nixon
DOI: https://doi.org/10.1016/j.ultrasmedbio.2009.06.537
IF: 3.694
2009-01-01
Ultrasound in Medicine & Biology
Abstract:To study the value of myocardial contrast echocardiography (MCE) and color Doppler coronary flow imaging (CDCFI) in transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy (HOCM) patients. A total of 94 HOCM patients who underwent evaluation for TASH were divided into three groups: Group 1 (n=32): myocardial contrast echocardiography (MCE) alone; Group 2 (n=37): MCE during procedure combined with color Doppler coronary flow imaging (CDCFI); Group 3 (n=25): MCE during and post procedure combined with CDCFI. In group 1, 1 patient had a 3rd degree AV block, 7 patients were found no appropriate vessels for ablation during procedure, 2 patients were found to have suboptimal ablation during post-op follow up. In Group 2, no serious complications occurred, 4 patients had no suitable vessel for ablation founded by CDCFI before procedure. 3 patients were found to have suboptimal ablation during follow up. In Group 3, no serious complications occurred, 2 patients had no suitable vessel for ablation founded by CDCFI before procedure, and 2 patients were found to have suboptimal ablation immediately after the procedure. No patients were found to have suboptimal ablation during follow up. In follow up, 5 of 94 patients developed post procedural LVOT gradients detected by MCE. The application of CDCFI and MCE assists in the selection of suitable patients and correct vessels for ablation, in the identification of post procedural LVOT gradients, in a reduction in the incidence of complications in patients undergoing TASH.
What problem does this paper attempt to address?